Clinical Trial Update: PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide [Phase 2]

View source ↗

Summary

Phase 2 trial PMRR-NO investigates pulmonary metabolic radiation response versus exhaled nitric oxide in patients with esophageal and lung cancer; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Gastrointestinal Disease, Esophageal Cancer | Phase 2 | Status: COMPLETED